文献速递肝胆胰外科围术期管理与 ERAS

胰腺癌静脉切除重建术后门肠系膜静脉血栓:时机、发生率与危险因素

Portomesenteric Venous Thrombosis After Pancreatic Cancer Surgery With Venous Resection and Reconstruction: Timing, Incidence, and Risk Factors.
PubMed 文献 · Ann Surg · 2024-12-16

该单中心回顾性研究纳入2012年1月至2023年6月于科罗拉多大学医院接受胰腺切除联合门肠系膜静脉切除重建的152例胰腺癌患者,分析门肠系膜静脉血栓(PVT)的发生率与危险因素。结果显示早期PVT发生率为3.3%,技术标准化后由12%降至1.6%(P=0.03);晚期PVT发生率为21.5%,中位诊断时间7.4个月,多与局部复发(75%)同时诊断,且与更短的无复发生存期相关(中位9.0 vs 16.3个月,P=0.014)。多因素分析显示新辅助放疗(HR 2.19,95%CI 1.02-4.67)和局部复发(HR 5.21,95%CI 2.18-12.4)与晚期PVT风险增加相关。

要点

  • 胰腺癌静脉切除重建术后早期PVT罕见,技术标准化后发生率显著下降。
  • 晚期PVT多发于术后中位7.4个月,常与局部复发同时诊断。
  • 新辅助放疗和局部复发是晚期PVT的独立危险因素。

核心结论

  • 胰腺切除联合门肠系膜静脉切除重建术后早期PVT罕见,晚期PVT与新辅助放疗及局部复发相关。

研究设计与样本

  • 单中心回顾性研究,纳入2012年1月至2023年6月科罗拉多大学医院接受胰腺切除联合门肠系膜静脉切除重建的胰腺癌患者152例。
  • 以2018年8月实施PVR技术本地标准化为界划分研究时段,PVT按术后≤30天或>30天分为早期和晚期。
  • 采用Cox回归模型评估晚期PVT的危险因素。

主要发现

  • 152例患者中早期PVT发生率为3.3%(n=5),技术标准化后由12%(n=3/25)降至1.6%(n=2/127),P=0.03。
  • 130例有术后影像学资料的患者中,晚期PVT发生率为21.5%(n=28),中位诊断时间距手术7.4个月。
  • 晚期PVT常与局部复发同时诊断(75%),并与更短的无复发生存期相关(中位9.0 vs 16.3个月,P=0.014)。
  • 多因素分析显示新辅助放疗(HR 2.19,95%CI 1.02-4.67)和局部复发(HR 5.21,95%CI 2.18-12.4)与晚期PVT风险增加相关。

临床怎么用

  • 对接受胰腺切除联合门肠系膜静脉切除重建的患者,尤其是新辅助放疗后或出现局部复发者,应警惕晚期PVT风险。
  • 技术标准化可能有助于降低早期PVT发生率。

局限性

  • 单中心回顾性设计,样本量有限,结论外推需谨慎。
  • 晚期PVT分析仅基于130例有术后影像学资料的患者,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the incidence and risk factors of portomesenteric venous thrombosis (PVT) after pancreatic cancer surgery with portomesenteric venous resection (PVR). BACKGROUND: Pancreatic cancer surgery with PVR can be complicated by PVT, but the long-term associations, risk factors, and consequences of PVT have not been clearly elucidated. METHODS: This study included pancreatic cancer patients undergoing any type of pancreatic resection with PVR at the University of Colorado Hospital between January 2012 and June 2023. The study period was divided based on the implementation of local standardization of PVR techniques in August 2018. PVT was classified as early or late (≤ or >30 d postoperatively). Risk factors for late PVT were assessed with Cox regression models. RESULTS: Among 152 patients, 3.3% (n=5) developed early PVT. Its incidence decreased from 12% (n=3/25) to 1.6% (n=2/127) after technical standardization ( P =0.03). Of 130 patients with available postoperative imaging, 21.5% (n=28) developed late PVT at a median of 7.4 months from surgery. Late PVT was frequently diagnosed with local recurrence (75%) and was associated with shorter recurrence-free survival (median 9.0 vs 16.3 mo, P =0.014). Multivariable analysis showed that neoadjuvant radiotherapy (hazard ratio, 2.19; 95% CI: 1.02-4.67) and local recurrence (HR, 5.21; 95% CI: 2.18-12.4) were associated with an increased risk of late PVT. CONCLUSIONS: Early PVT after pancreatectomy with PVR is rare. Late PVT is associated with neoadjuvant radiotherapy and local recurrence. These findings may inform risk assessment in pancreatic cancer patients undergoing PVR.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Ishida H, Watanabe S, Rodriguez Franco S, et al. Portomesenteric Venous Thrombosis After Pancreatic Cancer Surgery With Venous Resection and Reconstruction: Timing, Incidence, and Risk Factors. Ann Surg. 2024. PMID: 39676646. doi:10.1097/SLA.0000000000006605

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。